International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments--introduction.
about
Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticityMultidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticitySpotlight on botulinum toxin and its potential in the treatment of stroke-related spasticityAdvances in rehabilitation medicineConsensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosusSurvey of Botulinum Toxin Injections in Anticoagulated Patients: Korean Physiatrists' Preference in Controlling Anticoagulation Profile Prior to Intramuscular Injection.Use of botulinum toxin type A in the management of patients with neurological disorders: a national surveySafety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study.Poststroke hypertonicity: upper limb assessment and treatment.Salivary gland botulinum toxin injections for drooling in children with cerebral palsy and neurodevelopmental disability: a systematic review.Efficacy of botulinum toxin A in children with cerebral palsy in Gross Motor Function Classification System levels IV and V: a systematic review.Conversion ratio between Dysport and Botox in clinical practice: an overview of available evidence.The effectiveness of therapy on outcome following (BoNT-A) injection for focal spasticity in adults with neurological conditions: A systematic review.Systematic review of adjunct therapies to improve outcomes following botulinum toxin injection for treatment of limb spasticity.Do clinical tests of spasticity accurately reflect muscle function during walking: A systematic review.The use of botulinum toxin type A in the management of adult-onset focal spasticity: a survey of Australian allied health professionals.Botulinum toxin--how a poison turned to a fascinating ally against an old adversary.
P2860
Q24202197-28FC6A19-EA1A-4FFA-8A80-0E5C729099E4Q24203617-CD7452FC-80EA-40C4-8ECD-5EC580B13C69Q26750450-F0158C2A-4BD4-4208-B646-FA06E3D6C698Q27028176-B8BF4A89-267B-481A-B1D8-2D04E5B340C2Q36278355-E07B6B2B-1DA9-4747-982E-6C8561B14006Q36864584-A3048689-AFCF-4694-A459-D4C442AF29F9Q37632889-F8635918-C868-451D-A8AD-404F6F926704Q37737039-CF428C3A-7C45-410A-8559-9B74A22D3BABQ37885037-D6402480-4190-4633-82BC-709ADDF531BCQ38040438-1D82B98A-97D0-4C89-957E-7691404996F2Q38055255-7F8AC6A7-86E6-4C25-8EB7-8813E7BA1453Q38098126-5CE54515-2AEC-460B-8A7E-2055110F292CQ38397501-6AC3B0AE-2DE5-49A2-B30C-F748E6C496BEQ38551789-4A6D20AA-ED5E-49C7-BAF7-1FD969AEA3E7Q38925041-02E88AC5-670E-49DB-97B4-10824B660EF8Q45945324-D6E34E85-CC6D-4CEB-A644-52AE8DE7B57EQ48072414-548DB127-BFF7-4386-A5FD-061C0B7FBA9D
P2860
International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments--introduction.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
International consensus statem ...... cal impairments--introduction.
@en
International consensus statem ...... cal impairments--introduction.
@nl
type
label
International consensus statem ...... cal impairments--introduction.
@en
International consensus statem ...... cal impairments--introduction.
@nl
prefLabel
International consensus statem ...... cal impairments--introduction.
@en
International consensus statem ...... cal impairments--introduction.
@nl
P2093
P1476
International consensus statem ...... cal impairments--introduction.
@en
P2093
P356
10.1111/J.1468-1331.2010.03125.X
P478
17 Suppl 2
P577
2010-08-01T00:00:00Z